mRNA vaccines for HBV: Mechanisms, preclinical advances, and therapeutic clinical progress
Nadezhda A. Pechnikova(Aristotle University of Thessaloniki), Alexey V. Yaremenko(Brigham and Women's Hospital), Malamati Poimenidou(Aristotle University of Thessaloniki), Chrysi Patsidou(Aristotle University of Thessaloniki), Ioannis Iliadis(Aristotle University of Thessaloniki), Maria Zafeiriou-Chatziefraimidou(Aristotle University of Thessaloniki), Yu. V. Ostankova(Saint Petersburg Pasteur Institute)
Cited by 2
Related Papers
Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects
|Med|2022|222
Nanoparticle-based drug delivery <i>via</i> RBC-hitchhiking for the inhibition of lung metastases growth
|Nanoscale|2018|180
Oral drug delivery platforms for biomedical applications
|Materials Today|2023|123
Fast processes of nanoparticle blood clearance: Comprehensive study
|Journal of Controlled Release|2020|93